Clinical Study

Differences in Salivary Flow Level, Xerostomia, and Flavor Alteration in Mexican HIV Patients Who Did or Did Not Receive Antiretroviral Therapy

Table 2

Salivary flow and hyposalivation between groups.

With HAARTWithout HAARTOR and significance

Salivary flowMean and DSMean and DS
36.3 ± 22.243.4 ± 27.7P = 0.031*
Hyposalivation % %
 With7475.5%2424.5%P = 0.047Δ
OR = 0.557 (CI 0.323–0.962)
 Without12263.2%7136.8%

Resource: Civil Hospital “Fray Antonio Alcalde” HIV Unit.
test; confidence interval percentage of 95%.
Student’s t-Test.